Universal Health Services Inc. Cl B Stock Underperforms Wednesday When Compared To Competitors

Dow Jones11-07

DJ Universal Health Services Inc. Cl B Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Universal Health Services Inc. Cl B $(UHS)$ slid 4.08% to $203.52 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 2.53% to 5,929.04 and the Dow Jones Industrial Average rising 3.57% to 43,729.93.

The stock's fall snapped a three-day winning streak.

Universal Health Services Inc. Cl B closed $39.73 short of its 52-week high ($243.25), which the company reached on September 24th.

The stock underperformed when compared to some of its competitors Wednesday, as Select Medical Holdings Corp. (SEM) rose 3.01% to $38.33, Community Health Systems Inc. (CYH) remained unchanged, and Pediatrix Medical Group Inc. (MD) rose 4.69% to $16.08.

Trading volume (1.4 M) eclipsed its 50-day average volume of 754,053.

Data source: Dow Jones Market Data, FactSet. Data compiled November 6, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 06, 2024 17:18 ET (22:18 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment